Back to results
Not yet recruitingPhase 2

Study of Radiation Therapy in Combination With Darolutamide + Degarelix in Intermediate Risk Prostate Cancer

NCT04176081

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

UHN Princess Margaret Hospital

Toronto, Ontario, Canada

Contact

Sunakshi Chowdhary

416-946-4501Sunakshi.Chowdhary@uhn.ca
View on ClinicalTrials.gov
Study of Radiation Therapy in Combination With Darolutamide + Degarelix in Intermediate Risk Prostate Cancer — TrialFind